Neutron diffraction studies of the interaction between amphotericin B and lipid-sterol model membranes

Fabrizia Foglia1, M Jayne Lawrence, Bruno Demeė

  • 1Institute of Pharmaceutical Science, King's College London, London, UK.

Scientific Reports
|October 31, 2012
PubMed

Insights

Amphotericin treats fungal infections but causes side effects and resistance. Neutron diffraction reveals it forms pores in fungal and mammalian membranes, explaining its selective toxicity.

Area of Science:

  • Biophysics
  • Structural Biology
  • Antimicrobial Research

Background:

  • Amphotericin is a vital antifungal drug for systemic infections.
  • Clinical use is limited by severe side effects and emerging drug resistance.
  • Understanding amphotericin's molecular mechanism is crucial for developing new antifungals.

Purpose of the Study:

  • To elucidate the molecular mechanism of amphotericin action.
  • To investigate amphotericin's interaction with lipid-sterol membranes using neutron diffraction.

Main Methods:

  • Neutron diffraction studies were conducted.
  • The incorporation and effects of amphotericin within fungal and mammalian membranes were analyzed.
  • Interactions with membrane sterols (ergosterol and cholesterol) were examined.

Main Results:

  • Amphotericin disrupts the structure of both fungal and mammalian membranes.
  • The drug co-localizes with membrane sterols, suggesting trans-membrane pore formation.
  • Differences in membrane lipid ordering and drug-sterol complex distribution indicate selective toxicity towards fungal cells.

Conclusions:

  • Neutron diffraction provides insights into amphotericin's membrane interaction and pore-forming capability.
  • Observed differences in drug-sterol interactions explain amphotericin's selective toxicity against fungal pathogens.
  • This research aids in the rational design of novel antifungal agents with improved profiles.